Dominant Dystrophic Epidermolysis Bullosa

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-03-12
Clinical Trial Update: A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa [Phase 3]
Phase 3 study evaluating KB803 versus matched placebo in Dystrophic Epidermolysis Bullosa is currently recruiting.